Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Rating) have been given an average recommendation of “Buy” by the thirteen research firms that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target […]